Literature DB >> 16943428

Pleiotropic phenotype of a genomic knock-in of an RGS-insensitive G184S Gnai2 allele.

Xinyan Huang1, Ying Fu, Raelene A Charbeneau, Thomas L Saunders, Douglas K Taylor, Kurt D Hankenson, Mark W Russell, Louis G D'Alecy, Richard R Neubig.   

Abstract

Signal transduction via guanine nucleotide binding proteins (G proteins) is involved in cardiovascular, neural, endocrine, and immune cell function. Regulators of G protein signaling (RGS proteins) speed the turn-off of G protein signals and inhibit signal transduction, but the in vivo roles of RGS proteins remain poorly defined. To overcome the redundancy of RGS functions and reveal the total contribution of RGS regulation at the Galpha(i2) subunit, we prepared a genomic knock-in of the RGS-insensitive G184S Gnai2 allele. The Galpha(i2)(G184S) knock-in mice show a dramatic and complex phenotype affecting multiple organ systems (heart, myeloid, skeletal, and central nervous system). Both homozygotes and heterozygotes demonstrate reduced viability and decreased body weight. Other phenotypes include shortened long bones, a markedly enlarged spleen, elevated neutrophil counts, an enlarged heart, and behavioral hyperactivity. Heterozygous Galpha(i2)(+/G184S) mice show some but not all of these abnormalities. Thus, loss of RGS actions at Galpha(i2) produces a dramatic and pleiotropic phenotype which is more evident than the phenotype seen for individual RGS protein knockouts.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16943428      PMCID: PMC1592866          DOI: 10.1128/MCB.00314-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  72 in total

Review 1.  RGS protein and G protein interactions: a little help from their friends.

Authors:  John R Hepler
Journal:  Mol Pharmacol       Date:  2003-09       Impact factor: 4.436

2.  Endogenous RGS proteins and Galpha subtypes differentially control muscarinic and adenosine-mediated chronotropic effects.

Authors:  Ying Fu; Xinyan Huang; Huailing Zhong; Richard M Mortensen; Louis G D'Alecy; Richard R Neubig
Journal:  Circ Res       Date:  2006-02-02       Impact factor: 17.367

3.  Inhibition of receptor-mediated release of arachidonic acid by pertussis toxin.

Authors:  G M Bokoch; A G Gilman
Journal:  Cell       Date:  1984-12       Impact factor: 41.582

4.  Essential role for RGS9 in opiate action.

Authors:  Venetia Zachariou; Dan Georgescu; Nick Sanchez; Zia Rahman; Ralph DiLeone; Olivier Berton; Rachael L Neve; Laura J Sim-Selley; Dana E Selley; Stephen J Gold; Eric J Nestler
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

5.  Echocardiographic assessment of age-associated changes in systolic and diastolic function of the female F344 rat heart.

Authors:  Marvin O Boluyt; Kimber Converso; Hyun Seok Hwang; Agdas Mikkor; Mark W Russell
Journal:  J Appl Physiol (1985)       Date:  2003-10-10

6.  Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span.

Authors:  Karen T Coschigano; Amy N Holland; Markus E Riders; Edward O List; Allan Flyvbjerg; John J Kopchick
Journal:  Endocrinology       Date:  2003-09       Impact factor: 4.736

Review 7.  Is RGS-2 a new drug development target in cardiovascular disease?

Authors:  Sheila A Doggrell
Journal:  Expert Opin Ther Targets       Date:  2004-08       Impact factor: 6.902

8.  Endogenous regulator of G protein signaling proteins suppress Galphao-dependent, mu-opioid agonist-mediated adenylyl cyclase supersensitization.

Authors:  Mary J Clark; Richard R Neubig; John R Traynor
Journal:  J Pharmacol Exp Ther       Date:  2004-03-10       Impact factor: 4.030

Review 9.  Regulators of G protein signaling: potential drug targets for controlling cardiovascular and immune function.

Authors:  H Cho; K Harrison; J H Kehrl
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2004-06

10.  Defects in RGS9 or its anchor protein R9AP in patients with slow photoreceptor deactivation.

Authors:  Koji M Nishiguchi; Michael A Sandberg; Aart C Kooijman; Kirill A Martemyanov; Jan W R Pott; Stephanie A Hagstrom; Vadim Y Arshavsky; Eliot L Berson; Thaddeus P Dryja
Journal:  Nature       Date:  2004-01-01       Impact factor: 49.962

View more
  42 in total

1.  RGS inhibition at G(alpha)i2 selectively potentiates 5-HT1A-mediated antidepressant effects.

Authors:  Jeffery N Talbot; Emily M Jutkiewicz; Steven M Graves; Crystal F Clemans; Melanie R Nicol; Richard M Mortensen; Xinyan Huang; Richard R Neubig; John R Traynor
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-02       Impact factor: 11.205

2.  Beta-agonist-associated reduction in RGS5 expression promotes airway smooth muscle hyper-responsiveness.

Authors:  Zhao Yang; Philip R Cooper; Gautam Damera; Indranil Mukhopadhyay; Hyeseon Cho; John H Kehrl; Reynold A Panettieri; Kirk M Druey
Journal:  J Biol Chem       Date:  2011-01-29       Impact factor: 5.157

3.  The Role of Inhibitory G Proteins and Regulators of G Protein Signaling in the in vivo Control of Heart Rate and Predisposition to Cardiac Arrhythmias.

Authors:  Richard Ang; Aaisha Opel; Andrew Tinker
Journal:  Front Physiol       Date:  2012-04-24       Impact factor: 4.566

Review 4.  Regulators of G-protein signaling and their Gα substrates: promises and challenges in their use as drug discovery targets.

Authors:  Adam J Kimple; Dustin E Bosch; Patrick M Giguère; David P Siderovski
Journal:  Pharmacol Rev       Date:  2011-07-07       Impact factor: 25.468

5.  Regulators of G protein signaling (RGS) proteins as drug targets: modulating G-protein-coupled receptor (GPCR) signal transduction.

Authors:  David L Roman; John R Traynor
Journal:  J Med Chem       Date:  2011-09-29       Impact factor: 7.446

6.  Filling GAPs in the understanding of cardioprotection induced by GPCR activation: RGS proteins modulate ischaemic injury.

Authors:  Ronald J Korthuis
Journal:  Cardiovasc Res       Date:  2011-05-24       Impact factor: 10.787

7.  Gα subunit coordinates with ephrin-B to balance self-renewal and differentiation in neural progenitor cells.

Authors:  Kiyohito Murai; Runxiang Qiu; Heying Zhang; Jun Wang; Chen Wu; Richard R Neubig; Qiang Lu
Journal:  Stem Cells       Date:  2010-09       Impact factor: 6.277

Review 8.  Regulation of G-protein-coupled signaling pathways in allergic inflammation.

Authors:  Kirk M Druey
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

9.  GNAI2 and regulators of G protein signaling as a potential Noonan syndrome mechanism.

Authors:  Xinyan Huang; Ying Fu; Raelene A Charbeneau; Richard R Neubig
Journal:  Med Hypotheses       Date:  2009-03-17       Impact factor: 1.538

Review 10.  R9AP and R7BP: traffic cops for the RGS7 family in phototransduction and neuronal GPCR signaling.

Authors:  Muralidharan Jayaraman; Hao Zhou; Lixia Jia; Matthew D Cain; Kendall J Blumer
Journal:  Trends Pharmacol Sci       Date:  2008-11-29       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.